Discovery of Novel 1-Azoniabicyclo[2.2.2]octane Muscarinic Acetylcholine Receptor Antagonists
- 24 March 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 52 (8) , 2493-2505
Abstract
A novel 4-hydroxyl(diphenyl)methyl substituted quinuclidine series was discovered as a very promising class of muscarinic antagonists. The structure−activity relationships of the connectivity of the diphenyl moiety to the quinuclidine core and around the ring nitrogen side chain are described. Computational docking studies using an homology model of the M3 receptor readily explained the observed structure−activity relationship of the various compounds. Compound 14o was identified as a very potent, slowly reversible M3 antagonist with a very long in vivo duration of bronchoprotection.Keywords
This publication has 26 references indexed in Scilit:
- Anticholinergic agents in asthma and COPDEuropean Journal of Pharmacology, 2006
- Muscarinic Receptor Subtype Pharmacology and Physiology2005
- Selective muscarinic receptor antagonists for airway diseasesCurrent Opinion in Pharmacology, 2001
- Chronic obstructive pulmonary disease: emerging therapiesCurrent Opinion in Chemical Biology, 2000
- Effects of inflammatory cells on neuronal M2 muscarinic receptor function in the lungLife Sciences, 1999
- Muscarinic Receptors—Characterization, coupling and functionPharmacology & Therapeutics, 1993
- A study of the muscarinic receptor subtype mediating mucus secretion in the cat trachea in vitroPulmonary Pharmacology, 1989
- Muscarinic receptor subtypes: implications for lung disease.Thorax, 1989
- The Role of Pirenzepine-sensitive (M1) Muscarinic Receptors in Vagally Mediated Bronchoconstriction in HumansAmerican Review of Respiratory Disease, 1989
- Postganglionic muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea‐pigBritish Journal of Pharmacology, 1986